FDAsafety guidance66% confidence
Wizcure Pharmaa Private Limited - 726378 - 06/24/2026
Source: FDA
Why This Matters
Why this matters: sets a safety guidance precedent in the same sub-indication (pain) as Strides Pharma; the same agency is already in play for this signal, so precedent weight is higher.
Regulatory Analysis
Supporting Context
- Therapeutic area
- Pain Management · NSAID
- Sub-indication
- Pain
Related signal: Strides Pharma's Piroxicam ANDA206136 Receives AP Status from FDA